We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Industry Insight

Developing Therapeutics for Huntington’s Disease: Challenges, Opportunities and the Future

Dr. Christian Landles explains why it is so challenging to develop therapeutics for rare diseases such as HD, and discusses the potential of approaches that target mutant huntingtin protein to improve treatment options for HD patients.
Industry Insight

Driving Forward Huntington’s Disease Research

Dr. Christian Landles highlights some of the progress made in recent years to improve our understanding of HD and its drivers.
Industry Insight

New Model Will Support Drug Discovery for Liver Disease NASH

To learn more about NASH “in-a-box” and how it can help to advance drug discovery for NASH, Technology Networks spoke to Dr. Audrey Dubourg.
Industry Insight

The Spotlight on mRNA: A Conversation With Moderna

Technology Networks had the pleasure of interviewing Sunny Himansu M.B.B.S., D.SM – associate director, infectious diseases at Moderna – to discuss the biotech company's pipeline, how a collaboration with IAVI aims to make mRNA-based preventives and therapeutics globally accessible and the future of mRNA in medicine.
Industry Insight

Investing in the Future of Our People and Our Planet Through Science

We spoke to Geoff Winkett and Michel van den Berge from Agilent, about the importance of fostering academia–industry relationships and how the issue of sustainability is shaping the way they approach the development of new and existing solutions.
Industry Insight

Live Biotherapeutics ‒ A Novel Way To Treat Disease

The intricate and intertwined nature of the host‒microbiota connection has garnered increasing interest from the scientific community in recent years, due to its known role in the development and progression of various diseases. 4D pharma has leveraged growing knowledge in the field, by creating a novel class of medicines called live biotherapeutic products (LBPs).
Industry Insight

Using Bioelectronic Assays To Advance Drug Discovery for Neurological Diseases

In this interview, Jim Ross highlights several recent examples of how bioelectronic assays are helping to advance drug discovery for neurological diseases ranging from pediatric epilepsy to Burning Man Syndrome.
Industry Insight

When We Become Leaders, How Do We Lead Science Towards Gender Equity?

Emulate's chief scientific officer, Dr. Lorna Ewart, talks about inspiring a new generation of women in STEM.
Industry Insight

The Bright Future of mRNA

Technology Networks interviewed Frank DeRosa, chief technology officer and head of research at the mRNA Center of Excellence, Sanofi, to discuss the “bright future” of mRNA platforms.
Industry Insight

Time for Proteomics To Shine

Technology Networks had the pleasure of interviewing Dr. Oliver Rinner, CEO at Biognosys, to learn more about some of the recent developments in proteomics, and discuss what the future could hold for the field.
Advertisement